DATA SECURITY TECHNOLOGIES LLC
Healthcare data integration and cleaning platform that links and deduplicates patient records across multiple organizations to enable predictive disease models
- Sector
- Digital health
- Total capital
- $1.2M
- Federal grants
- $1.2M
- 3 awards · 2016–2021
- Sector median 0 awards
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- first 2023
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Efficient and privacy-enhancing consent management for health informatics data sharing$253K
- Federal grantNSF · Phase II · SBIR Phase II: A Security, Privacy and Governance Policy Enforcement Framework for Big Data$750K
- Federal grantNSF · Phase I · SBIR Phase I: PrivateMR: A Security, Privacy and Governance Policy Enforcement Framework for Big Data$223K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 2- GrantedSystems And Methods For Proactive And Reactive Data SecurityUSPTOUS 12,067,112
- GrantedSystems And Methods For Proactive And Reactive Data SecurityUSPTOUS 11,620,378
Recent research by its founders
- Revisiting Code Debloating with Ground Truth-based Evaluation20260 cites
- SoK: A Tale of Reduction, Security, and Correctness - Evaluating Program Debloating Paradigms and Their Compositions20245 cites
- Evaluating Container Debloaters20235 cites
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .